Fat and fat-free mass as important determinants of body composition assessment in relation to sarcopenic obesity.
Fat and fat-free/muscle mass and their ratio reflecting the possible presence of obesity or sarcopenic obesity are important in assessing body composition.
The aim of the work was to assess the use of fat and fat-free mass and their ratio in the diagnosis of sarcopenic obesity, as well as correlations with selected anthropometric, somatic and biochemical parameters and indices.
The object of the study was a group of 201 women (20-68 aged) randomly selected from the population without the presence of a serious disease or without the use of medication. Body composition was assessed by the MFBIA method (InBody 720). We used the ratio of fat to fat-free mass (FM/FFM) to define sarcopenic obesity. A Biolis 24i Premium biochemical analyzer was used to determine biochemical parameters.
Using FM and FFM values and their mutual ratio, we identified women with a healthy body weight (28.9%), obese women (58.2%) and women with sarcopenic obesity (12.9%). Values of anthropometric parameters (body weight, BMI, WC, WHR, WHtR, BAI, FM (kg, %), FMI, VFA, FFM (kg), FFMI, SMM (kg), SMMI, ICW, ECW, TBW, CHC, HC), with the exception of FFM (%), SMM (%) and TBW (%), increased significantly with increasing FM/FFM values, so the highest values were found in subjects with sarcopenic obesity. In the case of biochemical parameters, with increasing FM/FFM values, the values of T-CH, LDL, TAG, GLU, hs-CRP, UA, systolic and diastolic blood pressure also increased, so the highest values were again found in women with sarcopenic obesity. HDL values, on the contrary, decreased. FM/FFM had the strongest positive association with the proportion of fat mass on body weight (r=0.989), then with FMI (r=0.980), FM (r=0.965), VFA (r=0.938), WHtR (r=0.937), BMI (r=0.922), WC (r=0.901. We found the strongest negative association with the proportion of FFM on body weight (r=-0.989), the proportion of total body water (r=-0.988) and the proportion of skeletal muscle mass (r=-0.987).
FM/FFM correlates excellently with FM and VFA and can be implemented to diagnose obesity. In order to comprehensively evaluate the state of health and body composition, the proportionality of not only fat, but also fat-free/muscle mass should be analyzed, because it turns out that a negative impact on health and survival is associated not only with an excessive amount of adipose tissue, but also with a lower muscle mass.
Gažarová M
,Bihari M
,Šoltís J
《-》
Obesity diagnosis and mortality risk based on a body shape index (ABSI) and other indices and anthropometric parameters in university students.
Obesity is a global epidemic and belongs to major risk factors for the most prevalent diseases. Anthropometric measures are simple, inexpensive, non-invasive tools to diagnosis obesity and to assess the risk of morbidity and mortality. The most widely used are body mass index (BMI), waist circumference (WC), waist-to-hip (WHR) and waist-to-height ratios, visceral fat area (VFA), body fat (BFP) and a new body shape index (ABSI).
The aim of this study was to examine the usefulness of the ABSI in obesity diagnosis compared with other anthropometric parameters like WC, WHR, BMI, VFA, and BFP. We also compared the predictability between ABSI and above mentioned common anthropometric indices.
The study group was composed of 236 university students. Body height, weight, WC was measured and BMI, WHR, ABSI and ABSI z-score were calculated. The anthropometric measurements were made by using InBody 720 (Biospace Co. Ltd., Seoul, Republic of Korea). Body composition, especially VFA, BFP, FFM was diagnosed by multifrequency bioelectrical impedance analysis. We evaluated the collected data statistically and graphically in Microsoft Office Excel 2010 (Los Angeles, CA, USA). Statistical analyses were performed using the program STATISTICA Cz version 10.
The diagnosis of obesity among participants according to anthropometric measures and indices showed considerable differences. We found that obesity was diagnosed according to waist circumference in 31% of participants. According to BMI 20.3% of subjects were overweight and 5.1% obese. With increasing BMI values, the values of WC, WHR and VFA also increased linearly. According to visceral fat area 11.4% of participants were in the risk obese group and by ABSI mortality risk there were 22% of subjects with high risk (4.8% and 28.3% for men and women, respectively) and 19.1% with very high risk (11.1% and 22% for men and women, respectively). VFA and BFP values increased with increasing risk of mortality, and in men also waist circumference values. When evaluating the ABSI in relation to BMI, the U-shaped curve was confirmed and in the case of WC the J-shaped curve. The FFM evaluation showed that the very low ABSI mortality risk group reached the highest values of this parameter and the lowest values showed the average mortality risk group, not only in the study group but also in male and female groups.
Our findings suggest the relevance of ABSI to screen at-risk population.
Gažarová M
,Galšneiderová M
,Mečiarová L
《-》
Inverse relationship between "a body shape index" (ABSI) and fat-free mass in women and men: Insights into mechanisms of sarcopenic obesity.
Sarcopenic obesity may be defined by a high fat to fat-free mass (FM/FFM) ratio. Skeletal muscle may be negatively influenced by the pro-inflammatory milieu associated with visceral fat, while the loading effect induced by a heavier body mass index (BMI) may enhance muscle anabolism. Recently, a new anthropometric measure based on waist circumference (A Body Shape Index, ABSI) was developed. In this study we have assessed the predictive power of ABSI on the FFM index (FFMI), a surrogate marker of lean mass.
Standard anthropometric parameters and ABSI as well as body composition data (fat and fat-free mass determined by bioelectrical impedance analysis) were assessed in 111 female and 89 male overweight/obese subjects, with no clinically significant co-morbidities. Groups with higher- or lower-ABSI were identified according to median values of this index.
In women and men, ABSI did not correlate with BMI, while multiple linear regression indicated that BMI (β-coefficients: 0.62 and 0.77, respectively) and ABSI (β-coefficients: -0.26 and -0.22, respectively) independently predicted FFMI (multiple R: 0.72 and 0.83, respectively, P < 0.001). Men and women with lower-ABSI exhibited significantly greater FFMI than the higher-ABSI groups for comparable values of BMI. In men, ABSI was correlated positively with C-reactive protein (CRP) (R = 0.30; P < 0.05) and negatively with the reciprocal of insulin (R = 0.28; P < 0.05), an index of insulin sensitivity. FM/FFM ratio significantly (P < 0.01) correlated with CRP (R = 0.31) in women only.
ABSI, a recently introduced marker of abdominal adiposity, may contribute to define the risk of sarcopenia in overweight/obese individuals.
Biolo G
,Di Girolamo FG
,Breglia A
,Chiuc M
,Baglio V
,Vinci P
,Toigo G
,Lucchin L
,Jurdana M
,Pražnikar ZJ
,Petelin A
,Mazzucco S
,Situlin R
... -
《-》